1st September 2021 | Pharma Updates
Pharmaceutical and Drug sectors led growth in Indias export from Special Economic Zones
Led by pharma and drugs sectors, India’s exports from special economic zones rose by 41.5% on a yoy basis to Rs 2.15 lakh crore.
Abbott launches formulation of carbetocin
The room-temperature stable formulation addresses the difficulties of shipment or temperature, which helps to provide treatment to patients with PPH.
Divi's Labs upbeat in Yearly General Management
The company had posted a net profit of Rs 492 cr in the April-June quarter of last year fiscal.
Dr Reddy's roll out the drug for intestines
The drugmaker has launched Cilidinium Bromide and Chlordiazepoxide Hydrochloride capsules in the United States market.
DHG join hands with Nexcure Pharma for the Middle East market
Devonian Health Group has entered into distribution, sales and marketing agreement with Nexcure Pharma to market and sell Purgenesis in the middle east.
India approves only a few FDCs
Companies that have state licenses for their fixed-dose combinations and have no objection certificates from DCGI need to file for CDSCO nod within six months.
Sun Pharma to commercialize Winlevi in America, Canada
Winlevi is indicated for the treatment of people with acne vulgaris.
